Journal of the Korean Medical Association

| Opinion

September 10, 2021

Current status of inflammatory bowel diseases in Korea

Suk-Kyun Yang

J Korean Med Assoc. 2021;64(9):572-577.

Background: Inflammatory bowel disease (IBD) is a disease of unknown origin that causes chronic inflammation of the intestines and is classified as either ulcerative colitis or Crohn’s disease. The incidence...

| Focused Issue of This Month

September 10, 2021

Epidemiology and diagnosis of inflammatory bowel diseases

Kang-Moon Lee

J Korean Med Assoc. 2021;64(9):579-587.

Background: Over the past three decades, inflammatory bowel diseases (IBD) have been rapidly increasing in the African, South American, and Asian countries, including Korea. However, in Korea, the public awareness...

| Focused Issue of This Month

September 10, 2021

Intestinal microbiota and inflammatory bowel diseases

Chang Soo Eun

J Korean Med Assoc. 2021;64(9):588-595.

Background: The prevalence of inflammatory bowel diseases (IBD) has been rapidly increasing over the past several decades in Korea. IBD appears to be resulted from inappropriate and chronic activation of...

| Focused Issue of This Month

September 10, 2021

Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators

You Sun Kim

J Korean Med Assoc. 2021;64(9):596-604.

Background: Recently, the incidence and prevalence rates of inflammatory bowel disease (IBD) have increased worldwide, including in Korea. Although there has been considerable progress in the management of IBD following...

| Focused Issue of This Month

September 10, 2021

Treatment of inflammatory bowel diseases: focusing on biologic agents and new therapies

Hyo Yeop Song, Geom Seog Seo

J Korean Med Assoc. 2021;64(9):605-613.

Background: The treatment of inflammatory bowel diseases has evolved with the development of anti-tumor necrosis factor agents. Despite the long-term effectiveness, many patients experience primary non-response, secondary loss of response,...

| Continuing Education Column

September 10, 2021

Classification, diagnosis, and treatment of vascular malformations

Joon Seok Lee, Ho Yun Chung

J Korean Med Assoc. 2021;64(9):614-621.

Background: In the 1980s, vascular anomalies were divided into two major subgroups—vascular tumors and vascular malformations—based on the functional framework. This concept has been fundamental to the management of vascular...

| Pharmacotherapeutics

September 10, 2021

Therapeutics for acute otitis media

Junghun Kown, Juyong Chung

J Korean Med Assoc. 2021;64(9):624-630.

Background: Acute otitis media (AOM) is diagnosed in patients with acute onset of signs and symptoms of inflammation in the middle ear, accompanied by middle ear effusion. AOM is a...

| Special Contribution

September 10, 2021

Anesthesiologist’s role as a communication coordinator of perioperative medicine: stressing the recognition of role in the changing medical atmosphere

Jun Heum Yon, Bong Jin Kang

J Korean Med Assoc. 2021;64(9):631-635.

Background: Perioperative care process in a hospital is considerably complex, involving multiple subprocesses, healthcare professionals, and systems in support of surgical care. The perioperative process is often the primary source...

| Special Contribution

September 10, 2021

The effects of COVID-19 on physician’s burnout: a systematic review

Min Ji Kang, Jeong Hun Park

J Korean Med Assoc. 2021;64(9):636-646.

Background: To suggest measures to prevent burnout of physicians during the coronavirus disease 2019 (COVID-19) pandemic, we conducted a systematic review of research on physician burnout due to COVID-19. Methods: Three...

Current status of inflammatory bowel diseases in Korea Suk-Kyun Yang J Korean Med Assoc. 2021;64(9):572-577. Opinion September 10, 2021 Full text PubReader ePub PDF	Epidemiology and diagnosis of inflammatory bowel diseases Kang-Moon Lee J Korean Med Assoc. 2021;64(9):579-587. Focused Issue of This Month September 10, 2021 Full text PubReader ePub PDF
Intestinal microbiota and inflammatory bowel diseases Chang Soo Eun J Korean Med Assoc. 2021;64(9):588-595. Focused Issue of This Month September 10, 2021 Full text PubReader ePub PDF	Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators You Sun Kim J Korean Med Assoc. 2021;64(9):596-604. Focused Issue of This Month September 10, 2021 Full text PubReader ePub PDF
Treatment of inflammatory bowel diseases: focusing on biologic agents and new therapies Hyo Yeop Song, Geom Seog Seo J Korean Med Assoc. 2021;64(9):605-613. Focused Issue of This Month September 10, 2021 Full text PubReader ePub PDF	Classification, diagnosis, and treatment of vascular malformations Joon Seok Lee, Ho Yun Chung J Korean Med Assoc. 2021;64(9):614-621. Continuing Education Column September 10, 2021 Full text PubReader ePub PDF Self-study
Therapeutics for acute otitis media Junghun Kown, Juyong Chung J Korean Med Assoc. 2021;64(9):624-630. Pharmacotherapeutics September 10, 2021 Full text PubReader ePub PDF	Anesthesiologist’s role as a communication coordinator of perioperative medicine: stressing the recognition of role in the changing medical atmosphere Jun Heum Yon, Bong Jin Kang J Korean Med Assoc. 2021;64(9):631-635. Special Contribution September 10, 2021 Full text PubReader ePub PDF
The effects of COVID-19 on physician’s burnout: a systematic review Min Ji Kang, Jeong Hun Park J Korean Med Assoc. 2021;64(9):636-646. Special Contribution September 10, 2021 Full text PubReader ePub PDF